COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01897012
Brief Title: Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas

First Submitted : July 8, 2013
First Submitted that Met QC Criteria : July 8, 2013
First Posted : July 11, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : January 25, 2019
Last Update Posted : January 28, 2019